JL Kielczewski, YPR Jarajapu, EL McFarland, … - Circulation Research, 2009 - pt.wkhealth.com From the Program in Stem Cell Biology and Regenerative Medicine (JLK, YJ, AA,
SLC, KHC, LCS, MBG); and Departments of Pharmacology and Therapeutics (JLK, YJ,
AA, SLC, KHC, LCS, MBG), Anatomy and Cell Biology (JC, MEB), Pharmaceutics ...
A Grochot-Przeczek, R Lach, J Mis, K … - PloS one, 2009 - pubmedcentral.nih.gov Heme oxygenase-1 (HO-1), a cytoprotective, pro-angiogenic and anti-inflammatory
enzyme, is strongly induced in injured tissues. Our aim was to clarify its role
in cutaneous wound healing. In wild type mice, maximal expression of HO-1 ... Related articles - All 8 versions
B Chen, L Guo, C Fan, S Bolisetty, R Joseph, … - American Journal of Pathology, 2009 - ASIP Thrombosis is a major complication during multiple vascular pathological
conditions during which HO-1 and its byproduct CO could provide significant
protection through attenuation of inflammation, endothelial cell damage, ... Related articles - All 3 versions
K Receptors, EPC Dysfunction - Circ Res, 2008 - pt.wkhealth.com The field of progenitor cell therapy appears to be poised to transform the
management of many cardiovascular dis- eases. In particular, the use of bone
marrow-derived mono- nuclear cells (BM-MNCs) and endothelial progenitor ... Related articles
A Avogaro, GP Fadini - Expert Rev. Endocrinol. Metab., 2009 - expert-reviews.com Endothelial progenitor cells (EPCs) are bone marrow-derived cells involved in
endothelial healing and angiogenesis. EPCs are considered an integrated
component of the cardiovascular system, which promotes vascular health. ...
- ►ahajournals.org MR Ward, J Lavoie, DJ Stewart - Circulation Research, 2008 - Am Heart Assoc The field of progenitor cell therapy appears to be poised to transform the
management of many cardiovascular diseases. In particular, the use of bone
marrow-derived mononuclear cells (BM-MNCs) and endothelial progenitor cells ... Related articles - All 5 versions